{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpce.simplecast.com%2Fepisodes%2Fadvanced-urothelial-cancer-part-1-ew2X_0Kz","width":444,"version":"1.0","type":"rich","title":"Advanced Urothelial Cancer: Applying New Therapeutic Options, Part 1","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/86952976-b928-4317-884c-2c7ba3b2ae4d/cf697106-09ae-457a-b0a4-6d11ef641d7a/pce-podcast-urothelial-cancer-part1-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/6b9546d7-acf4-491d-85ae-84898a2d50f1\" height=\"200\" width=\"100%\" title=\"Advanced Urothelial Cancer: Applying New Therapeutic Options, Part 1\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this episode, Arjun Balar, MD discusses the latest evidence supporting the management of patients with advanced urothelial cancer using novel therapies including immune checkpoint inhibitors and antibody-drug conjugagtes.  Claim your credit at pce.is/GIGU."}